| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |